Followers | 8 |
Posts | 838 |
Boards Moderated | 0 |
Alias Born | 12/27/2008 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, June 23, 2017 7:05:58 AM
With extra high volume and good price gain and lots of upside, why not? I timed this wrong about a week and a half ago, but this time it should be better.
James
Recent XBIT News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 04:57:05 PM
- XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer • GlobeNewswire Inc. • 06/18/2024 03:35:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 03:27:20 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 05:36:43 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 05:01:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 03:48:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 02:00:25 PM
- XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis • GlobeNewswire Inc. • 11/14/2023 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 07:41:46 PM
- XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke • GlobeNewswire Inc. • 09/26/2023 01:00:00 PM
- XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled, Multicenter Study for Natrunix in Pancreatic Cancer • GlobeNewswire Inc. • 08/30/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 03:18:47 PM
- XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial • GlobeNewswire Inc. • 08/08/2023 03:47:05 PM
FEATURED ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • Jul 30, 2024 8:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM